2021
DOI: 10.1002/ajh.26099
|View full text |Cite
|
Sign up to set email alerts
|

VPS4A mutation in syndromic congenital hemolytic anemia without obvious signs of dyserythropoiesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 10 publications
(30 reference statements)
0
5
0
Order By: Relevance
“…In addition to driving MVB biogenesis for receptor downregulation, the ESCRTs facilitate abscission during cytokinesis, the biogenesis of extracellular vesicles and many viruses, closure of the autophagosome, repairing plasma membrane lesions, and maintaining nuclear envelope integrity. The critical contributions of ESCRTs to mammalian physiology is highlighted by the embryonic lethality of mouse ESCRT knockout models [9][10][11] and the disease-associated mutations linked to ESCRT genes [13][14][15][16][17][18][19][20][21][22][23][24][25]. For example, the PTPN23 (HD-PTP) mouse knockout model is embryonic lethal [12], and mutations in HD-PTP/PTPN23 are linked to NEDBASS [26][27][28][29][30].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition to driving MVB biogenesis for receptor downregulation, the ESCRTs facilitate abscission during cytokinesis, the biogenesis of extracellular vesicles and many viruses, closure of the autophagosome, repairing plasma membrane lesions, and maintaining nuclear envelope integrity. The critical contributions of ESCRTs to mammalian physiology is highlighted by the embryonic lethality of mouse ESCRT knockout models [9][10][11] and the disease-associated mutations linked to ESCRT genes [13][14][15][16][17][18][19][20][21][22][23][24][25]. For example, the PTPN23 (HD-PTP) mouse knockout model is embryonic lethal [12], and mutations in HD-PTP/PTPN23 are linked to NEDBASS [26][27][28][29][30].…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with roles in diverse, important cellular processes, disrupted ESCRT function through knockout of ESCRT-0 (hrs) [9], ESCRT-I (tsg101) [10], ESCRT-III (chmp5) [11] or the ESCRT-associated factor HD-PTP (ptpn23) [12] result in embryonic lethality in mouse models. Moreover, mutations altering ESCRT function have been linked to congenital disorders including spastic paraplegia (SP80, UBAP1; SP53, Vps37A) [13][14][15], childhood cataracts (CTRCT31, CHMP4B) [16,17], frontotemporal dementia (FTD/ALS17, CHMP2B) [18][19][20][21], pontocerebellar hypoplasia (PCH8, CHMP1A) [22], cerebellar hypoplasia, cataracts, impaired intellectual development, congenital microcephaly, dystonia, dyserythropoietic anemia, and growth retardation (CIMDAG, VPS4A) [23][24][25] and neurodevelopmental disorder with structural brain anomalies, seizures and spasticity (NEDBASS, HDPTP/PTPN23) [26][27][28][29][30] (also reviewed in [31]). While the ESCRTs serve important roles facilitating development and maintaining organismal homeostasis, the lack of a viable ESCRT-deficient mouse model has precluded a deeper understanding of how this is achieved.…”
Section: Introductionmentioning
confidence: 99%
“…More recently, an additional patient with a severe neurodevelopmental disorder resulting from VPS4A mutation (p.Arg284Trp) has been reported [132]. This patient had severe transfusion-dependent anemia with brisk reticulocytosis but no evidence of dyserythropoiesis on bone marrow evaluation [132]. Notably, subtle dyserythropoitic findings can be seen in disorders of hereditary chronic hemolytic anemias, such as pyruvate kinase deficiency [121] and hereditary xerocytosis [121,135].…”
Section: Other Congenital Dyserythropoietic Anemiasmentioning
confidence: 99%
“…More recently, an additional patient with a severe neurodevelopmental disorder resulting from VPS4A mutation (p.Arg284Trp) has been reported [132]. This patient had severe transfusion-dependent anemia with brisk reticulocytosis but no evidence of dyserythropoiesis on bone marrow evaluation [132].…”
Section: Other Congenital Dyserythropoietic Anemiasmentioning
confidence: 99%
“…Symptoms arising from problems with muscle tone such as hypotonia and dystonia are also thought to be central in nature (Ganguly et al, 2021). In addition, mutations in VPS4A are associated with Congenital Dyserythropoietic Anemia (Seu et al, 2020; Lunati et al, 2021). VPS4A encodes a type I AAA-ATPase that was originally identified in yeast.…”
Section: Introductionmentioning
confidence: 99%